Effects of JNJ-38431055, a novel GPR119 receptor agonist, in randomized, double-blind, placebo-controlled studies in subjects with type 2 diabetes. (Q51359689)
Jump to navigation
Jump to search
scientific article published on 14 March 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Effects of JNJ-38431055, a novel GPR119 receptor agonist, in randomized, double-blind, placebo-controlled studies in subjects with type 2 diabetes. |
scientific article published on 14 March 2012 |
Statements
Effects of JNJ-38431055, a novel GPR119 receptor agonist, in randomized, double-blind, placebo-controlled studies in subjects with type 2 diabetes (English)
L B Katz
J J Gambale
P L Rothenberg
S R Vanapalli
N Vaccaro
L Xi
14 March 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference